Company Search:
Advanced Search
Sponsored Links
Idorsia Ltd Company Snapshot
Idorsia Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Idorsia Ltd with three other companies in this sector in Switzerland: Bachem Holding AG (2017 sales of 261.61 million Swiss Francs [US$269.98 million] of which 88% was Active Pharmaceutical Ingredients), BB Biotech AG (270.33 million Swiss Francs [US$278.98 million] of which 100% was Investing & Related Activity), and Basilea Pharmaceutica Limited (90.67 million Swiss Francs [US$93.57 million] of which 100% was Pharmaceutical Products).

Sales Analysis.
  Stock Performance Chart for Idorsia Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 23.10
(Figures in Swiss Francs)
1 Week -0.9%   13 Weeks 1.5%  
4 Weeks -21.3%   52 Weeks n/a  
Idorsia Ltd Key Data:
  Ticker: IDIA Country: Switzerland
  Exchanges: OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 158,085,000
(Year Ending Jan 2018).
Employees: N/A
  Currency: Swiss Francs Market Cap: 2,751,751,233
  Fiscal Yr Ends: December Shares Outstanding: 119,123,430
  Share Type: AKTIE Closely Held Shares: 49,296,812
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.